Ferguson Wellman Capital Management Inc. Trims Stake in Humana Inc. (NYSE:HUM)

Ferguson Wellman Capital Management Inc. lessened its position in Humana Inc. (NYSE:HUM) by 4.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 10,493 shares of the insurance provider’s stock after selling 457 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Humana were worth $2,662,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. FNY Investment Advisers LLC boosted its holdings in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after buying an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares in the last quarter. PDT Partners LLC grew its holdings in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after purchasing an additional 2,660 shares during the period. Secure Asset Management LLC bought a new position in shares of Humana during the fourth quarter valued at approximately $244,000. Finally, Ontario Teachers Pension Plan Board lifted its holdings in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after purchasing an additional 71,910 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HUM. Barclays upped their price target on Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 22nd. Piper Sandler raised their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Truist Financial raised their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Morgan Stanley upped their target price on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $297.68.

Humana Stock Performance

HUM opened at $274.06 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average is $274.21 and its 200 day moving average is $298.14. The company has a market cap of $33.00 billion, a price-to-earnings ratio of 24.27, a PEG ratio of 2.11 and a beta of 0.56. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.